GloriaPure Precision Medicine is a high-tech enterprise under Dean Diagnostics that focuses on the research and development, clinical transformation and application of a new generation of multi-group biomarker mass spectrometry detection technology. The company focuses on multiple application directions such as in vitro diagnosis, clinical research, metabolomics, environment and clinical toxicology, and under the guidance of the whole industry chain technology that runs through multiple omics to clinical applications, it provides services covering “products + services + management”. The overall solution for clinical mass spectrometry. Recently, Gloria has completed the C+ round of financing of tens of millions of yuan. This round of financing was participated by Chongqing Yufu’s biological health investment platform. This round of financing will focus on accelerating the listing process of self-developed innovative products.
This article is transferred from: https://www.itjuzi.com/investevent/13740804
This site is only for collection, and the copyright belongs to the original author.